Reference : Abnormal glucose metabolism in patients treated with antipsychotics.
Scientific journals : Article
Human health sciences : Psychiatry
Human health sciences : Endocrinology, metabolism & nutrition
http://hdl.handle.net/2268/8989
Abnormal glucose metabolism in patients treated with antipsychotics.
English
Scheen, André mailto [Université de Liège - ULiège > Département des sciences cliniques > Diabétologie, nutrition et maladie métaboliques - Médecine interne générale >]
De Hert, M. A. [> > > >]
2007
Diabetes and Metabolism
Masson
33
3
169-75
Yes (verified by ORBi)
1262-3636
Moulineaux Cedex 9
France
[en] Antipsychotic Agents/adverse effects ; Blood Glucose/drug effects/metabolism ; Diabetes Mellitus/chemically induced/epidemiology ; Humans ; Schizophrenia/drug therapy
[en] Second-generation (atypical) antipsychotic medications are of great benefit to a wide variety of people with psychiatric disorders, especially patients with schizophrenia. However, one constellation of adverse effects is an increased risk of obesity, diabetes, and metabolic syndrome. Increasing numbers of reports concerning impaired glucose tolerance, diabetes, and ketoacidosis have raised concerns about a possible association between abnormal glucose metabolism and treatment with atypical antipsychotics, although the question is still debated because of the presence of many confounding factors. A close relationship between drug-induced weight gain and risk of diabetes has been reported, emphasizing the role of insulin resistance. However, some cases of diabetes developed independently of weight gain, rather rapidly and possibly progressing to ketoacidosis, thus arguing for a severe impairment of insulin secretion. Another debated question is whether diabetes risk is a class action or a differential action. Although not fully scientifically proven yet, available evidence suggests that clozapine and olanzapine have a higher propensity to induce diabetes and metabolic syndrome compared with other atypical antipsychotic drugs, risperidone and quetiapine. Despite more limited available data, amisulpride, aripiprazole and ziprazidone showed less likelihood of precipitating diabetes. Interestingly, reversibility of drug-related diabetes has been reported with aripiprazole. The choice of atypical antipsychotic medication for a specific patient depends on many factors, but the likelihood of developing diabetes should become an important consideration. When prescribing an atypical antipsychotic, a commitment to careful baseline screening and follow-up monitoring is essential in order to mitigate the risk of developing diabetes and associated complications.
Researchers ; Professionals ; Students
http://hdl.handle.net/2268/8989
10.1016/j.diabet.2007.01.003
http://www.em-consulte.com/revue/diabet

File(s) associated to this reference

Fulltext file(s):

FileCommentaryVersionSizeAccess
Open access
Abnormal glucose metabolism in patients treated with antipsychotics_ocr.pdfAuthor postprint188.7 kBView/Open

Bookmark and Share SFX Query

All documents in ORBi are protected by a user license.